Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02929563Phase 3Completed
Phase 3, randomised, double-blind trial in Gastrointestinal Bleeding (GIB) comparing Pantoprazole with Placebo (2 arms). Primary endpoints: Effective screening at 30 days, Timely enrollment at 30 days and 2 more. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02929563.